Prevalence and Associated Factors for Non-adherence in Patients with Rheumatoid Arthritis = Prevalence and Associated Factors for Non-adherence in Patients with Rheumatoid Arthritis

다국어 초록 (Multilingual Abstract)

Objective. To estimate the prevalence of non-adherence to rheumatoid arthritis (RA) medication and identify the associated factors for non-adherence in RA patients. Methods. Among the KORean Observational study Network for Arthritis 3,523 patients who completed a questionnaire about the adherence to RA medication were analyzed. The patients were divided into two groups: 1) adherent group, patients who skipped medication ≤5 days within the past 2 months; and 2) non-adherent group, patients who skipped ≥6 days of medication. The baseline characteristics were compared, and multivariable regression analysis was performed to identify the associated factors for non-adherence. Results. The non-adherent group had 339 patients (9.6%). The common causes of non-adherence were forgetfulness (45.8%), absence of RA symptoms (24.7%), and discomfort with RA medication (13.1%). Younger age (odds ratio [OR] 1.02, p＜0.01) and higher income (OR 1.70, p＜0.01) were associated with an increased risk of non-adherence. Whereas higher functional disability (OR 0.68, p＜0.01) and oral corticosteroid use (OR 0.73, p=0.02) were associated with a decreased risk of non-adherence. The associated factors differed according to cause of non-adherence. Having adverse events (OR 2.65, p=0.02) was associated with the risk of non-adherence due to discomfort with RA medication while a higher level of education (OR 2.37, p=0.03) was associated with the risk of non-adherence due to an absence of RA symptoms. Conclusion. The 9.6% of Korean RA patients were non-adherent to RA medication. The associated factors differed according to the cause of non-adherence. Therefore, an individualized approach will be needed to improve the adherence to RA medication. (J Rheum Dis 2018;25:47-57)

참고문헌 (Reference)

1 Xia Y, "Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis" 10 : 735-742, 2016

2 Welsing PM, "The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis" 44 : 2009-2017, 2001

3 Treharne GJ, "Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity" 5 : 175-190, 2007

4 Zwikker HE, "Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis" 8 : 1635-1645, 2014

5 Wawruch M, "Patient-related characteristics associated with non-persistence with statin therapy in elderly patients following an ischemic stroke" 26 : 201-207, 2017

6 Pasma A, "Non-adherence to disease- modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease" 17 : 281-, 2015

7 Cannon GW, "Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice" 63 : 1680-1690, 2011

8 Cramer JA, "Medication compliance and persistence: terminology and definitions" 11 : 44-47, 2008

9 Treharne GJ, "Medication adherence in rheumatoid arthritis: effects of psychosocial factors" 9 : 337-349, 2004

10 Park DC, "Medication adherence in rheumatoid arthritis patients: older is wiser" 47 : 172-183, 1999

11 van den Bemt BJ, "Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature" 8 : 337-351, 2012

12 Sung YK, "Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea" 41 : 745-751, 2012

13 Contreras-Yanez I, "Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs" 340 : 282-290, 2010

14 Michetti P, "Impact of treatment-related beliefs on medication adherence in immune-mediated inflammatory diseases: results of the global ALIGN study" 34 : 91-108, 2017

15 Tuncay R, "Factors affecting drug treatment compliance in patients with rheumatoid arthritis" 27 : 743-746, 2007

16 Firestein GS, "Evolving concepts of rheumatoid arthritis" 423 : 356-361, 2003

17 Rapoff MA, "Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis" 53 : 905-910, 2005

18 Waimann CA, "Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence" 65 : 1421-1429, 2013

19 Koneru S, "Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting" 57 : 1000-1006, 2007

20 Kuriya B, "Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH)" 41 : 2161-2166, 2014

21 Pasma A, "Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?" 12 : e0171070-, 2017

22 De Cuyper E, "Determinants of methotrexate adherence in rheumatoid arthritis patients" 35 : 1335-1339, 2016

23 Brus H, "Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations" 36 : 57-64, 1999

24 Kumar K, "Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study" 16 : 396-, 2015

25 Brandstetter S, "Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study" 2016

26 Horne R, "Compliance, adherence, and concordance: implications for asthma treatment" 130 (130): 65S-72S, 2006

27 Viller F, "Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study" 26 : 2114-2122, 1999

28 DiBenedetti DB, "Assessing methotrexate adherence in rheumatoid arthritis: a cross-sectional survey" 2 : 73-84, 2015

29 Choi SC, "An antimicrobial peptide-A3: effects on growth performance, nutrient retention, intestinal and faecal microflora and intestinal morphology of broilers" 54 : 738-746, 2013

30 Curtis JR, "Agreement between rheumatologist and patient-reported adherence to methotrexate in a US rheumatoid arthritis registry" 43 : 1027-1029, 2016

31 Osterberg L, "Adherence to medication" 353 : 487-497, 2005

32 Salt E, "Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature" 29 : 260-275, 2010

33 Wabe N, "Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD users" 37 : 897-904, 2017

34 van den Bemt BJ, "Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs" 36 : 2164-2170, 2009

35 Singh JA, "2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis" 64 : 625-639, 2012